1. Home
  2. ARMP vs TCGL Comparison

ARMP vs TCGL Comparison

Compare ARMP & TCGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$7.77

Market Cap

125.7M

Sector

Health Care

ML Signal

HOLD

TCGL

TechCreate Group Ltd. Class A Ordinary Shares

N/A

Current Price

$5.83

Market Cap

109.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ARMP
TCGL
Founded
N/A
2015
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
125.7M
109.5M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
ARMP
TCGL
Price
$7.77
$5.83
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
32.6K
701.3K
Earning Date
11-12-2025
02-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,054,000.00
$2,580,927.00
Revenue This Year
$4.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.80
52 Week Low
$0.90
$3.95
52 Week High
$16.34
$5.91

Technical Indicators

Market Signals
Indicator
ARMP
TCGL
Relative Strength Index (RSI) 64.63 N/A
Support Level $5.87 N/A
Resistance Level $6.60 N/A
Average True Range (ATR) 0.52 0.00
MACD 0.09 0.00
Stochastic Oscillator 89.55 0.00

Price Performance

Historical Comparison
ARMP
TCGL

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About TCGL TechCreate Group Ltd. Class A Ordinary Shares

TechCreate Group Ltd is a technology consultancy and advanced software solution provider offering a comprehensive range of payment, cybersecurity, and digital services and solutions. It serves large institutions, financial institutions and telecommunication companies, by providing them with payment, cybersecurity, and digital solutions such as, the development of RTE, RTP, API management and other services, such as cybersecurity defense, IT infrastructure, and cloud services. Its core business areas comprise: (1) the provision of professional services, (2) the sale of software licenses and maintenance licenses, and (3) the sale of hardware solutions.

Share on Social Networks: